ClinConnect ClinConnect Logo
Search / Trial NCT05245253

Trauma and Critical Care Exposure Examined With PET (TRAPETS)

Launched by KAROLINSKA UNIVERSITY HOSPITAL · Feb 16, 2022

Trial Information

Current as of November 11, 2025

Recruiting

Keywords

ClinConnect Summary

The TRAPETS trial is studying how trauma and serious illness affect the brain and thinking abilities. Researchers want to learn more about the impact of being in an intensive care unit (ICU) after a traumatic injury. To do this, they will closely examine twenty trauma patients over a year using special imaging tests, brain activity monitoring, and cognitive tests. These examinations will take place within three weeks of the injury, then again after three months, and finally after twelve months.

To participate in this study, patients must be between 20 and 60 years old and have experienced a significant injury. They should also be able to provide informed consent, meaning they understand the study and agree to take part. Those with certain pre-existing conditions, such as severe mental health disorders or a history of serious brain injuries, cannot join the trial. Participants can expect regular check-ups and tests that will help researchers understand how trauma affects both the brain and the body over time.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients 20-60 years of age.
  • 2. Trauma with an ISS score of ≥15
  • 3. Informed consent
  • Exclusion Criteria:
  • 1. Patient´s refusal to participate in the trial
  • 2. Any traumatic brain or spinal injury prior to admission
  • 3. Disabling neuropsychiatric disorder (dementia-diagnosis, Mb Alzheimer, Mb Parkinson, schizophrenia or severe mental depression prior to ICU admission)
  • 4. Any preadmission history of stroke with neurological sequelae
  • 5. Co-morbidities prior to ICU admission such as severe cardiac, hepatic, hematological or renal impairment
  • 6. Terminal phase of chronic disease or malignancy
  • 7. High-dose steroid treatment before ICU admission or during ICU care
  • 8. Presumed uncooperativeness or legal incapacity

About Karolinska University Hospital

Karolinska University Hospital is a leading academic medical center in Sweden, renowned for its commitment to advanced healthcare research and innovative clinical practices. As a key sponsor of clinical trials, the hospital leverages its extensive expertise in medical research and collaboration with Karolinska Institutet, one of the world's foremost medical universities. The institution is dedicated to enhancing patient care through rigorous scientific investigation, focusing on a wide range of therapeutic areas. With a multidisciplinary approach and a strong emphasis on translational medicine, Karolinska University Hospital aims to bridge the gap between laboratory findings and clinical application, ultimately striving to improve health outcomes and advance medical knowledge.

Locations

Stockholm, Sweden

Patients applied

0 patients applied

Trial Officials

Lars I Eriksson, Professor

Study Chair

Karolinska Institutet

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials